Apricus Biosciences - könnte interessant werden


Seite 2 von 4
Neuester Beitrag: 25.04.21 00:40
Eröffnet am:16.02.12 17:05von: Bootsektor_1Anzahl Beiträge:100
Neuester Beitrag:25.04.21 00:40von: Jennifersydc.Leser gesamt:34.757
Forum:Hot-Stocks Leser heute:4
Bewertet mit:
3


 
Seite: < 1 |
| 3 | 4 >  

271 Postings, 4288 Tage migut1News

 
  
    #26
01.09.15 13:35
Es wird heute wieder  fliegen!!!!  

271 Postings, 4288 Tage migut1Das war der Grund

 
  
    #27
01.09.15 13:51
SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros® in Italy by Bracco SpA. Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"), is also marketed under the trademark Vytaros® in Belgium and Virirec(TM) in Spain. This is the seventh country in the European Union in which the product has been launched, including France, Italy, Germany, the United Kingdom, Spain, Belgium and Sweden. In total, Vitaros is currently approved under the European Decentralized Procedure ("DCP") in twenty-two countries, of which fourteen have further approved Vitaros for commercialization at the national phase level of the DCP approval process.

Richard Pascoe, Chief Executive Officer of Apricus, commented, "We are pleased to announce Bracco's launch of Vitaros, the first on-demand topical treatment, in Italy, Europe's second largest ED treatment market which Bracco estimates to be approximately $135 million. As another contributor towards the positive momentum of commercialization by our partners, which recently produced 103% growth in units quarter over quarter, Bracco plans to implement a strong promotional strategy targeted at physicians across Italy. With this news, the product is now launched in the five largest markets in Europe."

In December 2010, Apricus signed an exclusive license agreement with Bracco to market Vitaros, in Italy, Vatican City and San Marino (the "Territory"). Under the terms of the agreement, Apricus has received $1.3 million in up-front and milestone payments from Bracco. Apricus is also eligible to receive milestone payments on future sales, plus double-digit tiered royalties based on Bracco's net sales of the product in the Territory.  In exchange, Bracco has the exclusive right to commercialize Vitaros in the Territory.  In addition, Bracco has agreed to certain minimum marketing commitments for Vitaros.  

867 Postings, 5981 Tage mariosapfNews

 
  
    #28
11.09.15 22:00
die News von gestern ist wohl nicht so toll ( angekommen ) !? oder weshalb fällt die heute so stark ???  

313 Postings, 3791 Tage OnkaPhase 2 Ergebnisse

 
  
    #29
16.02.16 21:11

313 Postings, 3791 Tage OnkaOder früher?

 
  
    #30
16.02.16 21:15

Laut der neusten Präsentation vom 08.02.2016:

Fispemifene top-line Phase 2b data in Q1 2016 

http://phx.corporate-ir.net/...NoaWxkSUQ9MzIyMTk4fFR5cGU9MQ==&t=1


 

313 Postings, 3791 Tage OnkaJahresergebnis

 
  
    #31
08.03.16 08:05

werden morgen veröffentlicht. Sarissa besitzt nun über 30 % Anteile an Apricus:

http://secfilings.nasdaq.com/...FA&RcvdDate=3%2F7%2F2016&pdf=wir

 

313 Postings, 3791 Tage OnkaJahresbericht

 
  
    #32
09.03.16 22:09

519 Postings, 3785 Tage biotech1x1Phase 2 Ergebnisse

 
  
    #33
23.03.16 22:08
... sollten die Tage nun released werden. Der Anstieg könnte ein positiver Vorbote sein. Schon $1,28 AH in Übersee.
LG, biotech  

313 Postings, 3791 Tage OnkaStudienergebnisse sind da

 
  
    #34
28.03.16 13:16

313 Postings, 3791 Tage OnkaZusammenfassung Webcast

 
  
    #35
29.03.16 00:23


Anyone listen to today's webcast?

NDA for Vitaros US target in Q3 2016, with hope for approval 6 months hence

Reduce spending by 30% by streamlining

Capital needs greatly reduced

Operating income needs and length of sustainability will be recalculated 

No mention of milestones  


RayVa orphan status feedback will be pursued, forgot what Pascoe said about timeframe for 2B


Organic growth of Vitaros in European countries already launched


Grow Vitaros Europe with additional launches in approved countries and seek approval in additional countries



Well this certainly was bad news today, but I came here for Vitaros, so I guess I'll just have to suck it up and see how the original instincts line up...

http://www.siliconinvestor.com/readmsg.aspx?msgid=30520192



 

313 Postings, 3791 Tage OnkaWarten

 
  
    #36
01.04.16 18:06
Angehängte Grafik:
apri.png (verkleinert auf 42%) vergrößern
apri.png

313 Postings, 3791 Tage OnkaKostenreduzierung

 
  
    #37
06.04.16 15:10

Apricus Biosciences, Inc. Wednesday said plans to prioritize the Vitaros commercial and regulatory activities and to deprioritize all other pipeline programs. The company expects 30 percent reduction in staff and cash-based operating expenses. It will also cut short the size of the director board and cash compensation.

http://www.nasdaq.com/article/...ff-operating-expenses-20160406-00250

 

313 Postings, 3791 Tage OnkaNews

 
  
    #38
25.07.16 14:00
Apricus Biosciences Further Expands Existing Vitaros® Partnership with Ferring Pharmaceuticals in Europe and Asia

http://www.nasdaq.com/press-release/...rmaceuticals-in-20160725-00181

 

313 Postings, 3791 Tage OnkaNews

 
  
    #39
27.07.16 14:12
Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon
http://www.nasdaq.com/press-release/...-dysfunction-in-20160727-00295
 

313 Postings, 3791 Tage OnkaNews

 
  
    #40
10.08.16 13:50

Completion of Transfer of Vitaros® German Marketing Authorization to Ferring Pharmaceuticals

http://www.nasdaq.com/press-release/...uthorization-to-20160810-00205

 

313 Postings, 3791 Tage OnkaNews

 
  
    #41
15.08.16 13:35

Apricus Biosciences Announces Completion of Transfer of the United Kingdom Marketing Authorization for Vitaros® to Ferring Pharmaceuticals


http://www.nasdaq.com/press-release/...g-authorization-20160815-00151

 

3965 Postings, 3683 Tage warkla2nicht schlecht

 
  
    #43
18.01.17 18:15
da war ich mal wieder schlau!!!!  

313 Postings, 3791 Tage OnkaVon der Konferenz heute

 
  
    #44
14.02.17 17:54

 
Angehängte Grafik:
2017-02-14_1751.png (verkleinert auf 64%) vergrößern
2017-02-14_1751.png

313 Postings, 3791 Tage OnkaHier die Präsentation

 
  
    #45
15.02.17 16:27

3965 Postings, 3683 Tage warkla2wunderbar

 
  
    #46
09.03.17 09:50
die Party geht weiter!!!!!!  

313 Postings, 3791 Tage OnkaYepp

 
  
    #47
09.03.17 10:14

Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals

http://www.nasdaq.com/press-release/...pharmaceuticals-20170308-01117


 

3965 Postings, 3683 Tage warkla2habe schon

 
  
    #48
12.03.17 11:58
sehr gute Gewinne mit der Aktie gemacht.
Lege trotzdem noch mal nach!!!
Keine Kaufe.....  

720 Postings, 2716 Tage SwityNa heute wird sie wohl ,die gewinne

 
  
    #49
12.05.17 15:29
von gestern wieder abgeben. Bin ab heute trotzdem in der aktie investiert.  

Seite: < 1 |
| 3 | 4 >  
   Antwort einfügen - nach oben